Chemotherapy and concomitant irradiation in inflammatory breast cancer

Anticancer Research

Volumn 21, Issue 4 B, 2001, Pages 3061-3067

  Tubiana Mathieu, N ^a   Lejeune, C ^a   Bonnier, P ^a   Genet, D ^a   Adjadj, D J ^a   Berdah, J F ^a   Muracciole, X ^a   Delaby, F ^a   Clavere, P ^a   Benyoub, A ^a   Roullet, B ^a   Rhein, B ^a   Juin, P ^a   Piana, L ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Breast cancer; Inflammatory breast cancer; Radiochemotherapy

Indexed keywords

CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; HEMOPOIETIC GROWTH FACTOR; METHOTREXATE; METHYLPREDNISOLONE; VINDESINE;

ADULT; AGED; ANEMIA; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HORMONAL THERAPY; HUMAN; INFLAMMATORY BREAST CANCER; MASTECTOMY; METASTASIS; MULTIMODALITY CANCER THERAPY; NEUTROPENIA; PRIORITY JOURNAL; RADIATION DOSE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; EPIRUBICIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; GONADOTROPIN-RELEASING HORMONE; HEMATOLOGIC DISEASES; HUMANS; LIFE TABLES; MENOPAUSE; METHOTREXATE; MIDDLE AGED; NEOPLASM METASTASIS; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; SURVIVAL ANALYSIS; TAMOXIFEN; THROMBOPHLEBITIS; TREATMENT OUTCOME; VINDESINE;

EID: 0035160099     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Inflammatory breast cancer†: A review
2. Inflammatory breast carcinoma incidence and survival. The surveillance, epidemiology and results program of the national cancer institute 1975-1992
3. Inflammatory carcinoma of the breast: A report of twenty-eight cases from the breast clinic of Memorial Hospital
4. Inflammatory carcinoma of the breast
5. Clinically occult inflammatory carcinoma of the breast
6. Inflammatory carcinoma of the breast
7. Prognostic factors in inflammatory breast cancer: Univariate and multivariate analysis
8. Inflammatory carcinoma of the breast
9. Inflammatory breast cancer: The experience of the Surveillance, Epidemiology and End results program (SEER)
10. Concomitant chemo-radio-therapy: Rational and clinical experience in patients with solid tumors
11. How American oncologists treat breast cancer: An assessment of the influence of clinical trials
12. Results of initial doxorubucin, 5 fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast
13. Six-year results of a multimodality treatment strategy for locally advanced breast cancer
14. Induction chemotherapy with cisplatin, doxorubicin and cyclophosphamide (CAP) in a combined modality approach for locally advanced and inflammatory breast cancer long term results
15. Cisplatin and radiation: Interaction probabilities and therapeutic possibilities
16. Rationale for different chemotherapeutic and radiation therapy strategies in cancer management
17. The influence of time sequence of cisplatin administration and continuous low-dose-rate irradiation
18. Alternating radiotherapy and chemotherapy in nonmetastatic inflammatory breast cancer
19. Association concomitante radiothérapie-chimiothérapie dans le cancer du sein inflammatoire. Résultats preliminaires d'un essai phase II
20. Multimodal treatment for inflammatory breast cancer
21. Accelerated fractionation vs hyperfractionation: Rationales for several treatments per day
22. Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy
23. Inflammatory breast cancer: Integration of irradiation, Surgery, and chemotherapy
24. Pathological assessment of response to induction chemotherapy in breast cancer
25. Inflammatory carcinoma of the breast: Treatment results on 107 patients
26. Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation
27. The centre Henri Becquerel studies in inflammatory non metastatic breast cancer: Combined modality approach in 178 patients
28. Combined modality treatment of inflammatory breast carcinoma: Twenty years of experience at MD Anderson Cancer Center
29. Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma
30. Therapy of inflammatory breast cancer: Impact of doxorubicin- based therapy
31. Inflammatory carcinoma of the breast: Results of a modality approach at MD Anderson Cancer Center experience
32. Initial chemo-immunotherapy in inflammatory carcinoma of the breast
33. Treatment of patients with inflammatory breast cancer
34. Treatment of inflammatory cancer of the breast: Combined chemotherapy and radiotherapy. Concerning 270 women treated at the Institut Gustave Roussy
35. High-dose chemotherapy and haematologic stem-cell transplantation for inflammatory breast cancer†: Pathologic response and outcome
36. First line high-dose sequential chemotherapy with G-CSF and repeated blood stem-cell transplantation in untreated inflammatory breast cancer: Toxicity and response (Pegase 02 trial)
37. Can high-dose chemotherapy and peripheral blood progenitor rescue improve survival of patients with stage III B, inflammatory breast cancer progression free and overall survival and predictors of outcome in 74 patients
38. High dose chemotherapy with autologous hematopoietic progenitor cell support as part of combined modality therapy in patients with inflammatory breast cancer
39. High-dose therapy for breast cancer
40. Long term results of intensive chemotherapy with autologous bone narrow transplantations for inflammatory breast cancer
41. Inflammatory carcinoma of the breast: A correlation of clinical, radiologic and pathologic findings